Join the Oncology Voice Network. Join for Free
Diversity in Medical Affairs and the Power of Networking
networking in medical affairs DEMA mission career advancement tips medical affairs professionals diversity in medical affairs

Diversity in Medical Affairs and the Power of Networking


Share This Article


Summary

In this episode, Tom Caravela welcomes guests Rachel Kennedy, Lashondra Taylor, and Nirav Shah to discuss the formation and mission of DEMA. They explore the transformative power of networking, sharing Rachel's inspiration behind DEMA and how to engage with the organization. The conversation includes networking success stories and valuable advice for new MSLs and job seekers. The guests outline DEMA's current initiatives and future plans, highlighting upcoming events. The episode concludes with updates from Tom and expressions of appreciation for the listeners' support.

My guests today are Rachel Kennedy, LaShaundra Taylor, and Nirav Shah from DiMA (Diversity in Medical Affairs) and we discuss the story of DiMA and the power of networking.

In this episode we discuss:

  • Intro of Rachel, LaShaundra, and Nirav
  • The story of how the DiMA group was formed
  • What is the mission and how can people join or get involved?
  • Their advice for medical affairs professionals on networking and how it can advance their career
  • Examples of how networking has helped them in their careers.
  • Other advice to those that are looking to build a career in Medical Affairs

Click for Source
networking in medical affairs, DEMA mission, career advancement tips, medical affairs professionals, diversity in medical affairs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Fierce Pharma Engage 2025 - RECAP
Partner Avatar MSL Talk: Tom Caravela, Patrina Pellett

Fierce Pharma Engage 2025 - RECAP

Podcast
Time Audit: YOUR Strategy for Time Management Success
Partner Avatar MSL Talk: Tom Caravela, Patrina Pellett

Time Audit: YOUR Strategy for Time Management Success

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN